A recent meta-analysis demonstrated that the BRAFV600E mutation significantly increased the risk of RAI-R differentiated thyroid cancer, and also identified the TERT promoter mutation as an important factor for RAI-R (69, 70) which, in turn, is well-established to correlate with older patient age (71–78). The gene discussed is TERT; the disease is thyroid cancer.